HOME | ABOUT US | MEDIA KIT | CONTACT US | INQUIRE
A clinical trial company in Lenexa, Kansas gains capital resources through an investment from private equity firm in San Francisco. Photo Credit: Shutterstock
Posted August 30, 2023
Lenexa-based Johnson County Clin-Trials (JCCT) is gaining a swell of equity as part of an investment from private equity firm San Francisco-based FFL Partners.
JCCT specializes in Phase I – IV clinical trials, specializing in healthy volunteers and special populations. The company has conducted approximately 300 clinical trials, engaging over 15,000 study participants, according to a release.
“Our collaboration with FFL infuses substantial resources that will power the expansion of our footprint, and we’re confident this investment will invigorate our patient recruitment endeavors and expedite our growth trajectory,” said Nathan Arthur, Co-CEO and Co-Founder of JCCT. “We’re eagerly anticipating the positive impact this partnership will have on expanding and enhancing the services we offer to our pharmaceutical sponsors and CROs.”
In conjunction with the investment, Jeanne Hecht, CEO and founder of JTH Consulting, will assume a role on the JCCT board of directors.
Financial terms of the private transaction were not disclosed.
View the full release, here.